Literature DB >> 12608975

Measuring the importance of attributes that influence consumer attitudes to colorectal cancer screening.

Glenn P Salkeld1, Michael J Solomon, Leonie Short, Jeanette Ward.   

Abstract

BACKGROUND: The aim of the present study was to rate the importance of attributes of screening for bowel cancer.
METHOD: Randomly selected households in central Sydney were contacted to identify men and women aged 50-70 years who were then asked to complete a self-administered questionnaire about bowel cancer screening and related issues. Seven hundred and ninety-one residents (362 men and 429 women) returned questionnaires. Respondents were asked to rate the extent to which each of 34 attributes would encourage them to participate in bowel cancer screening.
RESULTS: The three most highly rated attributes were: if the test was recommended by their general practitioner (GP; 94% either 'strongly agreed' or 'agreed'); if the test identified early cancers (92%); and if the test would avert a premature death due to bowel cancer (90%). Having a friend or relative with bowel cancer (61%), advertising (41%) or famous people promoting the program (62%) were less influential. Respondents who were unemployed or on a pension were less likely to participate in screening than those who were employed if there was an 'out of pocket' charge of 15.00 Australian dollars (chi 2 = 7.56, 2df, P = 0.006). Respondents with higher levels of education were significantly more concerned than respondents with lower levels of education about test accuracy (chi 2 = 15.76, 2df, P < 0.001), its availability from their local chemist (chi 2 = 16.96, 2df, P < 0.001), being able to return the test kit by post (chi 2 = 21.9, 2df, P < 0.001) or deposit it with their local chemist (chi 2 = 10.0, 2df, P < 0.01). They were also less likely to be influenced by a famous person promoting bowel cancer screening (chi 2 = 18.87, 2df, P < 0.001).
CONCLUSIONS: Our results endorse the role of the GP in bowel cancer screening. However, the study also has demonstrated that test accuracy, the convenience of the screening service and notification of test results are valued differently by subgroups in the community, according to their level of education.

Entities:  

Mesh:

Year:  2003        PMID: 12608975     DOI: 10.1046/j.1445-2197.2003.02650.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  9 in total

Review 1.  Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.

Authors:  S Wortley; G Wong; A Kieu; K Howard
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.

Authors:  Sarah Damery; Sue Clifford; Sue Wilson
Journal:  BMC Fam Pract       Date:  2010-03-09       Impact factor: 2.497

3.  Informed decision making changes test preferences for colorectal cancer screening in a diverse population.

Authors:  Navkiran K Shokar; Carol A Carlson; Susan C Weller
Journal:  Ann Fam Med       Date:  2010 Mar-Apr       Impact factor: 5.166

Review 4.  Bringing an organizational perspective to the optimal number of colorectal cancer screening options debate.

Authors:  Melissa R Partin; Adam A Powell; Diana J Burgess; Timothy J Wilt
Journal:  J Gen Intern Med       Date:  2011-09-14       Impact factor: 5.128

5.  How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.

Authors:  Deborah A Marshall; F Reed Johnson; Nathalie A Kulin; Semra Ozdemir; Judith M E Walsh; John K Marshall; Stephanie Van Bebber; Kathryn A Phillips
Journal:  Health Econ       Date:  2009-12       Impact factor: 3.046

6.  Patient perspectives on colorectal cancer screening and the role of general practice.

Authors:  Lynsey J Brown; S Leigh Roeger; Richard L Reed
Journal:  BMC Fam Pract       Date:  2019-07-29       Impact factor: 2.497

7.  Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.

Authors:  Joachim Worthington; Jie-Bin Lew; Eleonora Feletto; Carol A Holden; Daniel L Worthley; Caroline Miller; Karen Canfell
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

8.  Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study.

Authors:  Marianne F Weber; Michelle Cunich; David P Smith; Glenn Salkeld; Freddy Sitas; Dianne O'Connell
Journal:  BMC Public Health       Date:  2013-05-03       Impact factor: 3.295

9.  Public stated preferences and predicted uptake for genome-based colorectal cancer screening.

Authors:  Catharina G M Groothuis-Oudshoorn; Jilles M Fermont; Janine A van Til; Maarten J Ijzerman
Journal:  BMC Med Inform Decis Mak       Date:  2014-03-19       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.